To determine risk factors associated with adverse developmental outcome at 5 years in extremely low birth weight infants or extremely premature infants (<28 weeks) with normal neonatal cranial ultrasounds.
INTRODUCTION
The principal purpose of neonatal intensive care is to promote intact survival. With increasing survival of extremely low birth weight (ELBW) infants 1, 2 it has become important to determine factors that are associated with a poorer outcome. It is well established that infants with intraventricular haemorrhage (IVH) 3, 4 and periventricular leukomalacia (PVL) 5, 6 have a poorer developmental outcome. Abnormalities on cranial ultrasound imaging are predictive of adverse developmental outcomes 7, 8 and the absence of lesions used to reassure parents regarding positive outcomes for neurodevelopment.
In recent years it is becoming increasingly clear that other postnatal factors like the presence of chronic lung disease 9, 10 and the use of postnatal steroids 11, 12 might influence long-term neurodevelopment. However, the presence or absence of IVH/PVL might confound some of these results, as there may be an interaction between cranial ultrasound abnormalities and these factors. 10, 13 Therefore, the aim of this study was to examine the neurodevelopmental outcome of extremely premature (<28 weeks) or ELBW infants with normal cranial ultrasound findings in the neonatal period. The primary objective was to estimate the prevalence of developmental impairment in infants who would be expected to have a good developmental outcome and secondly to determine risk factors other than IVH/PVL that might be associated with an adverse outcome.
METHODS Patients
The Neonatal Intensive Care Unit (NICU) at Royal North Shore Hospital acts as a tertiary referral centre for Northern Sydney Health area and offers all services except surgical care. Since 1985, all infants with birth weight <1000 g or gestational age <28 weeks admitted to the NICU have been enrolled in a comprehensive longterm follow-up programme. Our study cohort comprised of infants from this group who were reported to have normal cranial ultrasounds throughout their nursery stay.
All children had cranial ultrasounds performed during the first and fourth weeks of life and prior to discharge. Additional scans were performed if clinically indicated or if any of these routine ultrasounds were abnormal. Qualified radiologists reported all the scans. IVH was classified using Papile's classification.
14 PVL was identified when cystic lesions were found in the periventricular white matter.
Data were collected prospectively on a number of variables including multiplicity of birth, method of admission (in utero or ex utero transfer), antenatal steroids (exposure or no exposure), gestational age (completed weeks), birth weight (grams), chronic lung disease (requiring oxygen at 36 weeks), days on ventilator, postnatal steroids (exposed or not exposed), peak serum bilirubin level (SBR), Apgar scores at 1 and 5 minutes, grade of retinopathy of prematurity (ROP), postnatal sepsis (blood culture proven), necrotising enterocolitis (radiological and clinical signs) and indomethacin treatment.
We stratified infants according to gestational age (<27 and Z27 weeks) and birth weight (<800 and Z800 g) to determine whether smaller or more premature infants had a worse prognosis than their bigger and more mature counterparts. Finally, we stratified infants having jaundice into those having serum bilirubin Z200 mmol/l (SBRZ200) and those who did not. All the above variables were tested, to determine any association with poor developmental outcome.
DEVELOPMENTAL ASSESSMENT Vision
All infants were screened for ROP at 32 to 34 weeks postconceptional age. Further review was arranged in the first 4 months following discharge if ROP was found in the neonatal period. All children had their vision screened at 1 and 5 years and were referred for further ophthalmologic review if their visual acuity on screening was <6/12 at 1 year or <6/6 at 5 years, or if there were any additional concerns regarding vision (e.g. presence of strabismus). Children were considered to have visual impairment if their visual acuity was r6/18 with glasses. Children were considered to be blind if their visual acuity was <6/60.
Hearing
Between 1985 and 1992, all children had their hearing formally assessed by an audiologist at 10 to 12 months corrected age. For children born from 1992 to 1995, all children had their hearing screened prior to discharge using Oto-acoustic emission. Children, who failed this screen, were further assessed using brain stem auditory-evoked potentials. Children in whom there were later concerns regarding hearing and children with delayed language development were referred for additional audiological assessment. Children were considered to have a hearing impairment if they had >30 dB hearing loss. Children with hearing loss Z90 dB were considered to have profound hearing loss.
Cerebral Palsy (CP) All children had a neurological assessment performed at 1 and 5 years by a paediatrician to detect cerebral palsy. Children were considered to have mild or moderate CP if they were ambulant but had abnormal neurological signs and impairment in motor function. They were considered to have severe CP if they were unable to walk independently at 5 years.
Intelligence Quotient (IQ) All children were assessed at 5 years by a psychologist using standardized tests of intelligence. The Stanford-Binet Intelligence Scale-4th Ed 15 was used for children born between 1985 and 1991 and the Wechsler Pre-School and Primary scale of Intelligence F Revised 16 was administered for children born between 1992 and 1995. Children were considered to have normal intelligence if IQ Z85, borderline intelligence if IQ was between 70 and 84 and significant intellectual impairment if IQ <70.
Classification of Impairment
For this study we classified children's development as 
Socio-Economic Status
Fathers' occupations were classified according to the Australian Classification of Occupations. For the purpose of the study, a child was considered to have a low socioeconomic background (low SES) if the father was either a semiskilled or unskilled worker.
STATISTICAL ANALYSIS
Data were analysed using SPSS software. Depending on whether the data were continuous, ordinal or categorical analysis of clinical variables was carried out initially using analysis of variance (ANOVA), Wilcoxon rank sum test and w 2 tests, respectively. Binary logistic regression was used to test for significance and estimate odds ratios (OR) and 95% confidence intervals (CI) for individual variables. Finally, all the variables that were individually significant for an outcome along with suspected confounding variables (gestational age, SES, chronic lung disease and postnatal steroids) were included in a multivariate analysis to determine which clinical variables influenced developmental outcome. Cochran-Armitage test was used to test for increasing trend of significant risk factors in children with no impairment, mild or moderate impairment and severe impairment.
RESULTS
A total of 352 infants with birth weight <1000 g or gestational age <28 weeks were cared for in our nursery over the study period. Of these 352, 189 had normal cranial ultrasound scans, 81 had abnormal scans (intraventricular haemorrhage and/or PVL) and 77 infants died before a cranial ultrasound had been performed. Five infants were excluded; as there was incomplete information on the cranial ultrasound scans. Of the 43 infants (43/81) with abnormal scans alive at 5 years of age, 13 infants (33%) had a normal outcome, 17 infants (42%) had mild/moderate impairment and 10 infants (25%) had severe developmental impairment.
Of the 189 children who had normal cranial ultrasound scans, 152 (80%) children survived to 5 years and formed our study group. The mean birth weight for the study cohort was 898 g (462 to 1295 g) and mean gestational age was 27.1 (23 to 33 weeks). A total of 120 infants had a birth weight less than 1000 g (37 with birth weight less than 800 g) and 32 infants had a birth weight >1000 g (all with gestational age <28weeks). In all, 57 infants were born at 23 to 26 weeks gestation and 95 infants were born at 27 weeks gestation or later.
Five-year outcomes were available for 144 (94%) infants. Of these, 89 (62%) had normal development, 39 (27%) had mild/ moderate impairment and 16 (11%) had severe impairment. Of the 55 infants with developmental impairment (mild, moderate or severe), 27 children had an IQ <85 as their only impairment, 15 children had an IQ<85 and other neurosensory impairment (vision, hearing and motor), while 13 children had a visual, hearing or motor abnormality with an IQ Z85. Table 1 shows the comparison between children who had no neurosensory impairment and those with ''some'' (mild, moderate or severe) neurosensory impairment with respect to various perinatal factors. Statistically significant differences were found in incidence of ROP and mean peak serum bilirubin in the two groups. The strength of association between perinatal risk factors and abnormal developmental outcome is shown in Tables 2 and 3 . Retinopathy of prematurity and peak serum bilirubin Z200 mmol/ l (11.6 mg/dl) were associated with ''some'' neurosensory impairment on univariate analysis and after controlling for confounders on multivariate analysis (Table 2) . Gestational age and birth weight were not associated with a poorer developmental outcome nor was there a difference in outcome between smaller infants and larger infants (<800 and Z800 g) or less and more mature infants (<27 and Z27 weeks). Chronic lung disease (CLD), use of postnatal steroids, use of antenatal steroids, Apgar scores r5 at 1 and 5 minutes, postnatal sepsis, NEC and use of indomethacin were not associated significantly with developmental impairment.
In all, 16 children (11.1%) had a severe impairment with three children having an IQ <70 as their only impairment, 12 children had an IQ <70 and other neurosensory impairment (6 had severe CP, five had visual acuity <6/60, five had hearing loss >90 dB), while one child had blindness as the sole impairment. On univariate analysis, serum bilirubin >200 mmol/l, retinopathy of prematurity and use of postnatal steroids were all associated with severe impairment. SBR Z200 continued to be associated with severe impairment after controlling for confounders on multivariate analysis (Table 3) To understand better the clinical implications of the association between serum bilirubin level and developmental outcome, we examined data relating to serum bilirubin more closely. SBR was measured in 109 of the 144 infants. A total of 45 (31%) had a maximum SBR >200 mmol/l, 10 (7%) infants had a maximum SBR>250 mmol/l. The highest recorded SBR for any infant was 295 mmol/l (20.5 mg/dl). Table 4 shows the association between SBR Z 200 mmol/L (11.6 mg/dl) and various neurosensory impairments. On univariate analysis, there was a significant association between SBR Z200 and hearing impairment, cerebral palsy, IQ less 85, IQ less than 70 but not visual impairment.
The mean serum bilirubin for children with no impairment, mild/moderate impairment and severe impairment was 175 mmol/l (10.1 mg/dl), 196 mmol/l (11.4 mg/dl) and 216 mmol/l (12.6 mg/ dl), respectively (ANOVA: F ¼ 6.53, p ¼ 0.002). A peak SBR Z200 mmol/l was measured in 18 of the 65 infants (28%) with no impairment, 16 of the 30 infants (53%) with mild/moderate impairment and 11 of the 14 infants (78%) with severe impairment, demonstrating an increasing trend (p<0.0001). Assuming that the 35 infants who did not have serum bilirubin measured would have had peak SBR r200 mmol/l we repeated the 
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Cochran-Armitage tests. Incidence of peak SBR Z200 mmol/l increased from 20% (18/89) to 41% (16/39) to 69% (11/16) in infants with no impairment to mild/moderate impairment to severe impairment, demonstrating an increasing trend ( p<0.0001). Screening for retinopathy of prematurity was performed in 136 of the 144 infants. ROP was associated with the development of ''some'' impairment and severe impairment. On univariate analysis ROP was associated with poor outcome for vision (OR ¼ 5.5, 95%CI ¼ 2.3 to 13.4), hearing (OR ¼ 1.6, 95%CI ¼ 1.1 to 2.3), IQ<70 (OR ¼ 1.7, 95%CI ¼ 1.2 to 2.6) and cerebral palsy (OR ¼ 1.6, 95%CI ¼ 1.00 to 2.4). ROP was present in 29 of the 85 infants (34%) with no neurosensory impairment, 15 of the 36 infants (42%) with mild or moderate impairment and in 11 of the 15 infants (73%) with severe impairment, demonstrating an increasing trend for ROP ( p<0.009).
DISCUSSION
Our study population consisted of 152 infants from a single centre over 10 years. This is a limitation of our study. Multicentre studies over a shorter time interval would definitely be more powerful in answering the questions we have tried to address. It is possible that such studies might identify other risk factors for neurosensory impairment which are more generalizable. On the other hand, this is one of the few studies that have comprehensively analysed developmental outcomes at 5 years in extremely premature or ELBW population with normal cranial ultrasounds with a 95% follow-up rate. The 5-year survival for infants with normal cranial ultrasounds in this study was 80%. Among the study cohort 55 infants (38%) had ''some'' neurosensory impairment with 27 of the 144 children (19%) having an IQ<85 as their only impairment. Both the survival and long-term neurodevelopmental outcome are comparable to those reported in other studies for infants with similar birth weight and gestational age. 3, [17] [18] [19] [20] Among variables analysed in this study we found that a serum bilirubin Z200 mmol/l, presence of ROP and use of postnatal steroids are postnatal risk factors associated with an adverse developmental outcome in infants with normal cranial ultrasounds. Previous studies assessing the association of serum bilirubin with developmental outcome in preterm infants have been confounded by inclusion of infants with intraventricular haemorrhage. Van De Bor M et al. 21, 22 reported that cerebral palsy was the major neurological sequel of neonatal hyperbilirubinemia 23 reported that peak serum bilirubin concentrations are directly correlated with hearing impairment and Psychomotor Developmental Index <70 in ELBW infants. Our data are consistent with these reports.
Variation in outcomes between studies on the association between hyperbilirubinaemia and neurodevelopmental outcome may also have been confounded by differing approaches to treatment of premature infants with elevated bilirubin levels. Scheidt et al. 24 used a very aggressive approach to treatment of jaundice, but did not find an association between maximum SBR and IQ at 6 years. A study by Graziani et al. 25 did not find any association between maximum serum bilirubin and developmental problems at 1 year in infants with or without neonatal intracranial haemorrhage. Infants in our study were managed using a less aggressive approach based on charts published by Cockington. 26 Serum bilirubin was measured only in clinically jaundiced infants. For infants with nonhaemolytic jaundice, phototherapy was commenced at bilirubin levels of 150 to 200 mmol/l (8.8 to 11.8 mg/dl) and exchange transfusion was considered when SBR was >250 mmol/l. There were no infants in the study group with haemolytic jaundice and none underwent exchange transfusion. Consensus guidelines for management of jaundice in this population did not exist during the time period of this study and there is continued debate about the risks and benefits of moderate hyperbilirubinaemia. It is unclear from our study whether the association between jaundice and developmental impairment was due to a direct effect of bilirubin on the developing brain, or whether elevated bilirubin is a marker of ''illness'' in sicker or more vulnerable infants. Hence, it is uncertain if more aggressive management of jaundice in our cohort would have changed outcomes. The Neonatal Research Network has recently implemented a randomized trial of aggressive versus conservative phototherapy to address this issue.
The association between ROP and handicap is not surprising as a higher grade of ROP contributes to visual handicap. While associations between IVH and ROP have been reported before, 27 ROP was associated with poor outcomes for hearing and cerebral palsy in our cohort with normal neonatal cranial ultrasound. Hungerford et al. 28 reported that in infants with gestational age <33 weeks ROP was strongly associated with evidence of brain damage, often consistent with hypoxic ischaemic injury. It might be that factors that contribute to development of ROP (prematurity, hypoxia-hyperoxia, etc) might adversely affect other areas in the developing brain. ROP acts as a marker for neonatal morbidity and its presence in severe grades should alert the physician towards the possibility of adverse developmental outcome in later years.
Several studies have shown an association between postnatal steroid use and adverse developmental outcomes. 29, 30 As our use of postnatal steroids over the period of study was confined to the sickest infants, it is not clear from our results whether postnatal steroid use is a cause of long-term developmental impairment, or whether its use is simply associated with infants at a high risk of neurosensory impairment. In this study, an association between CLD and neurodevelopmental impairment at 5 years was not evident, although a number of studies have found an association between CLD and developmental outcome. 9,10,31 However, Gray et al. 10 found that infants with severe bronchopulmonary dysplasia were not at increased risk of adverse developmental outcome once periventricular haemorrhage, sepsis and ventricular dilatation were taken into account. We did not have complete information on chorioamnionitis for our cohort although we realize it might be a possible confounding factor. ELBW or extremely premature infants are at significant risk of neurosensory impairment even in the absence of IVH or PVL by ultrasound imaging. Postnatal risk factors like the development of ROP, SBR Z200 mmol/l and use of postnatal steroids could adversely affect long-term neurodevelopment. Hence caution is warranted when counselling parents about the long-term risks of neurodevelopment in infants with normal cranial ultrasound. Further research is required to determine if modification of these factors, for example, by more aggressive treatment of hyperbilirubinaemia or avoidance of postnatal steroids, will result in any change in long-term outcome.
